Cargando…

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer

Detalles Bibliográficos
Autor principal:	Cristofanilli, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231893/ http://dx.doi.org/10.1186/bcr1213

Ejemplares similares

The role of magnetic resonance imaging as an imaging tool to assess disease status and residual disease in locally advanced breast cancer
por: Cristofanilli, M
Publicado: (2005)

Evaluation of interleukins 8 and 12, CA 15-3 and free circulating DNA as prognostic markers in dogs with mammary tumors
por: Gelaleti, Gabriela B, et al.
Publicado: (2013)

Development of novel oncology biomarkers for cancer
por: Yoganathan, Nathan
Publicado: (2014)

Expression profiling as a prognostic and predictive factor in breast cancer
por: van 't Veer, LJ
Publicado: (2005)

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer
por: van de Vijver, MJ
Publicado: (2005)

The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use
por: Davidson, N
Publicado: (2005)

The evaluation of prognostic value of serum tumor marker in ovarian tumors
por: Sharief, S, et al.
Publicado: (2015)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Tuberculosis reactivation during novel, biologic therapy
por: Popescu, Cristina, et al.
Publicado: (2013)

Expression profiling of breast cancer, influence of tumor genotype and patient genotype
por: Borresen-Dale, A-L
Publicado: (2003)

Tailored therapies based upon tumor subtype biology
por: Perou, CM
Publicado: (2005)

Breast tumor heterogeneity: causes and consequences
por: Polyak, K, et al.
Publicado: (2009)

Molecular characteristics of inherited breast tumors
por: Borg, Å, et al.
Publicado: (2000)

Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)
por: Nieto, Y
Publicado: (2005)

Stem cells in human breast development and cancer
por: Wicha, M, et al.
Publicado: (2005)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
por: Burmi, RS, et al.
Publicado: (2006)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification
por: Hotson, Drew, et al.
Publicado: (2014)

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)

Novel cerebrospinal fluid inflammatory biomarkers in neonatal post-hemorrhagic hydrocephalus
por: Habiyaremye, Gakwaya, et al.
Publicado: (2015)

Surgical treatment for bronhial carcinoid tumors prognostic factors for long-term outcome
por: Petrov, D, et al.
Publicado: (2013)

Steroid regulation of breast cancer cell proliferation
por: Sutherland, RL
Publicado: (2003)

Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells
por: Haymaker, Cara, et al.
Publicado: (2013)

Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research
por: Shiku, Hiroshi
Publicado: (2012)

The immune biology of microsatellite unstable cancer
por: von Knebel-Doeberitz, Magnus
Publicado: (2010)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Biological features and xenograft models of a very early human premalignant breast lesion
por: Lee, S, et al.
Publicado: (2005)

HIV-1 infection and circulating peripheral blood B cell subpopulations
por: Singh, Ravinder, et al.
Publicado: (2014)

Prognostic significance of E-Cadherin and CD44 expression in tumor tissue of colorectal carcinoma
por: Knezevic, T, et al.
Publicado: (2015)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

OA21 Are novel anti-IL5 biologics triggering rheumatoid arthritis?
por: Dean, Nathan, et al.
Publicado: (2023)

Spatial proteomics enables identification of prognostic biomarkers in papillary renal cell carcinoma
por: Haake, Scott, et al.
Publicado: (2023)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
por: Crépin, M, et al.
Publicado: (2003)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Activation of TGF-beta signalling in breast cancer metastatic cells
por: Giampieri, S, et al.
Publicado: (2008)

CSF circulation and cerebral cortex development
por: Miyan, Jaleel
Publicado: (2009)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_b90mug40kvtgdmevk13g282vfv